Siga Technologies (SIGA) Other Accumulated Expenses (2019 - 2025)
Siga Technologies' (SIGA) quarterly Other Accumulated Expenses came in at $869431.0 in Q4 2025, down 59.75% on a YoY basis from $2.2 million in Q4 2024, and down 22.8% quarter-over-quarter from $1.1 million in Q3 2025.
Analysis
Siga Technologies (SIGA) Other Accumulated Expenses (2019 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Other Accumulated Expenses for 7 consecutive years, with $869431.0 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Other Accumulated Expenses fell 59.75% year-over-year to $869431.0; the trailing twelve-month figure through Dec 2025 stood at $869431.0 (down 59.75% YoY), and the FY2025 full-year result was $869431.0, down 59.75% from the prior year.
- Other Accumulated Expenses slipped to $869431.0 in Q4 2025 per SIGA's latest filing, from $1.1 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $2.3 million in Q1 2025 and bottomed at $278788.0 in Q2 2021.
- Historically, Other Accumulated Expenses has averaged $1.3 million across 5 years, with a median of $1.2 million in 2022.
- The sharpest annual moves came in 2021 and 2022: Other Accumulated Expenses plunged 70.15% in 2021, then surged 235.29% in 2022.
- Over 5 years, Other Accumulated Expenses stood at $1.4 million in 2021, then slipped by 10.4% to $1.3 million in 2022, then soared by 63.36% to $2.1 million in 2023, then advanced by 3.49% to $2.2 million in 2024, then plunged by 59.75% to $869431.0 in 2025.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $869431.0, $1.1 million, and $1.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 869,431.00 |
| Sep 30, 2025 | 1.13 Mn |
| Jun 30, 2025 | 1.16 Mn |
| Mar 31, 2025 | 2.29 Mn |
| Dec 31, 2024 | 2.16 Mn |
| Sep 30, 2024 | 2.23 Mn |
| Jun 30, 2024 | 2.19 Mn |
| Mar 31, 2024 | 2.10 Mn |
| Dec 31, 2023 | 2.09 Mn |
| Sep 30, 2023 | 1.07 Mn |
| Jun 30, 2023 | 1.33 Mn |
| Mar 31, 2023 | 1.34 Mn |
| Dec 31, 2022 | 1.28 Mn |
| Sep 30, 2022 | 852,370.00 |
| Jun 30, 2022 | 934,745.00 |
| Mar 31, 2022 | 753,540.00 |
| Dec 31, 2021 | 1.43 Mn |
| Sep 30, 2021 | 416,966.00 |
| Jun 30, 2021 | 278,788.00 |
| Mar 31, 2021 | 286,476.00 |